No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Benzenesulfonates / therapeutic use*
-
Carcinoma, Renal Cell / blood
-
Carcinoma, Renal Cell / drug therapy*
-
Clinical Trials, Phase III as Topic
-
Disease-Free Survival
-
Humans
-
Kaplan-Meier Estimate
-
Kidney Neoplasms / blood
-
Kidney Neoplasms / drug therapy*
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Prognosis
-
Pyridines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Sorafenib
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / blood
Substances
-
Antineoplastic Agents
-
Benzenesulfonates
-
Phenylurea Compounds
-
Pyridines
-
Vascular Endothelial Growth Factor A
-
Niacinamide
-
Sorafenib